This Article Full Text Full Text (PDF) Other Versions of this Article: MCB.01636-06v1 27/12/4488    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhang, S. Articles by Chen, Y.-G. Search for Related Content PubMed PubMed Citation Articles by Zhang, S. Articles by Chen, Y.-G.

Smad7 Antagonizes Transforming Growth Factor ß Signaling in the Nucleus by Interfering with Functional Smad-DNA Complex Formation

State Key Laboratory of Biomembrane and Membrane Biotechnology, Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing 100084, China,¹ Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 77030²

Received 1 September 2006/ Returned for modification 16 October 2006/ Accepted 29 March 2007

Smad7 plays an essential role in the negative-feedback regulation of transforming growth factor ß (TGF-ß) signaling by inhibiting TGF-ß signaling at the receptor level. It can interfere with binding to type I receptors and thus activation of receptor-regulated Smads or recruit the E3 ubiquitin ligase Smurf to receptors and thus target them for degradation. Here, we report that Smad7 is predominantly localized in the nucleus of Hep3B cells. The targeted expression of Smad7 in the nucleus conferred superior inhibitory activity on TGF-ß signaling, as determined by reporter assay in mammalian cells and by its effect on zebrafish embryogenesis. Furthermore, Smad7 repressed Smad3/4-, Smad2/4-, and Smad1/4-enhanced reporter gene expression, indicating that Smad7 can function independently of type I receptors. An oligonucleotide precipitation assay revealed that Smad7 can specifically bind to the Smad-responsive element via its MH2 domain, and DNA-binding activity was further confirmed in vivo with the promoter of PAI-1, a TGF-ß target gene, by chromatin immunoprecipitation. Finally, we provide evidence that Smad7 disrupts the formation of the TGF-ß-induced functional Smad-DNA complex. Our findings suggest that Smad7 inhibits TGF-ß signaling in the nucleus by a novel mechanism.

Published ahead of print on 16 April 2007.

This article has been cited by other articles:

• Grant, C., Oh, U., Yao, K., Yamano, Y., Jacobson, S. (2008). Dysregulation of TGF-{beta} signaling and regulatory and effector T-cell function in virus-induced neuroinflammatory disease. Blood 111: 5601-5609 [Abstract] [Full Text]  
• Hu, H., Milstein, M., Bliss, J. M., Thai, M., Malhotra, G., Huynh, L. C., Colicelli, J. (2008). Integration of Transforming Growth Factor {beta} and RAS Signaling Silences a RAB5 Guanine Nucleotide Exchange Factor and Enhances Growth Factor-Directed Cell Migration. Mol. Cell. Biol. 28: 1573-1583 [Abstract] [Full Text]  
• Zhao, X., Nicholls, J. M., Chen, Y.-G. (2008). Severe Acute Respiratory Syndrome-associated Coronavirus Nucleocapsid Protein Interacts with Smad3 and Modulates Transforming Growth Factor-{beta} Signaling. J. Biol. Chem. 283: 3272-3280 [Abstract] [Full Text]  
• Xi, Q., He, W., Zhang, X. H.-F., Le, H.-V., Massague, J. (2008). Genome-wide Impact of the BRG1 SWI/SNF Chromatin Remodeler on the Transforming Growth Factor Transcriptional Program. J. Biol. Chem. 283: 1146-1155 [Abstract] [Full Text]